AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22429395 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline 0.9% solution); n = 47
Number of subjects: 92
Study 20492838 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 125
Study 20492838 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study 20492838 — intervention group
Group type: COMPARATOR
Intervention: Aripiprazole and Placebo
Number of subjects: 125
Study 18391054 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance-based protocol (ACT)
Number of subjects: 20
Study 18391054 — intervention group
Group type: COMPARATOR
Intervention: Cognitive control-based protocol (CONT)
Number of subjects: 20
Study 16158740 — intervention group
Group type: EXPERIMENTAL
Intervention: mitoxantron+cysplatin+prednisolone
Number of subjects: 59
Study 16158740 — intervention group
Group type: EXPERIMENTAL
Intervention: vinorelbin + cycloplatam
Number of subjects: 59
Study 16158740 — intervention group
Group type: EXPERIMENTAL
Intervention: mitoxantron + prednisolone
Number of subjects: 59
Study 12741431 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 81 mg/day
Number of subjects: 48
Study 12741431 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 1300 mg/day
Number of subjects: 48
Study 12741431 — intervention group
Group type: COMPARATOR
Intervention: Aspirin 325 mg/day
Number of subjects: 48
Study 10442912 — intervention group
Group type: EXPERIMENTAL
Intervention: Brimonidine 0.2% added to existing glaucoma medication regimen
Number of subjects: 96
Study 8523297 — intervention group
Group type: EXPERIMENTAL
Intervention: Sutureless cataract surgery
Number of subjects: 28
Study 8523297 — intervention group
Group type: COMPARATOR
Intervention: Sutured cataract surgery
Number of subjects: 28
Study 2212374 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (mean 27.5 mg) administered three times daily for at least 2 weeks
Number of subjects: 8
Study 2212374 — intervention group
Group type: COMPARATOR
Intervention: Placebo identical in appearance to isosorbide dinitrate
Number of subjects: 8
Study 331868 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrazepam 5 mg
Number of subjects: 0
Study 331868 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrazepam 10 mg
Number of subjects: 0
Study 331868 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrazepam 5 mg and 10 mg
Number of subjects: 0
Study 331868 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31838009 — intervention group
Group type: EXPERIMENTAL
Intervention: Oncokompas (eHealth application)
Number of subjects: 625
Study 31838009 — intervention group
Group type: COMPARATOR
Intervention: Control group (access to Oncokompas after 6 months)
Number of subjects: 625
Study 31629443 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (NAC)
Number of subjects: 3634
Study 31629443 — intervention group
Group type: COMPARATOR
Intervention: No chemotherapy
Number of subjects: 3634
Study 28152989 — intervention group
Group type: EXPERIMENTAL
Intervention: SQ-LNS with 0, 5 or 10 mg zinc, 6 mg iron, and 400 μg vitamin A, along with malaria and diarrhea treatment.
Number of subjects: 2435
Study 28152989 — intervention group
Group type: EXPERIMENTAL
Intervention: SQ-LNS with 10 mg zinc.
Number of subjects: 2435
Study 28152989 — intervention group
Group type: COMPARATOR
Intervention: NIC (non-intervention cohort).
Number of subjects: 2435
Study 26094394 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary supplement rekicen‐RD® in combination with antibacterial therapy
Number of subjects: 64
Study 26094394 — intervention group
Group type: COMPARATOR
Intervention: Standard antibacterial therapy
Number of subjects: 64
Study 23971711 — intervention group
Group type: EXPERIMENTAL
Intervention: HP‐PRRSV/PCV2 (group 1)
Number of subjects: 30
Study 23971711 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV2/HP‐PRRSV (group 2)
Number of subjects: 30
Study 23971711 — intervention group
Group type: EXPERIMENTAL
Intervention: HP‐PRRSV+PCV2 (group 3)
Number of subjects: 30
Study 23971711 — intervention group
Group type: EXPERIMENTAL
Intervention: HP‐PRRSV (group 4)
Number of subjects: 30
Study 23971711 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV2 (group 5)
Number of subjects: 30
Study 23971711 — intervention group
Group type: COMPARATOR
Intervention: Control (group 6)
Number of subjects: 30
Study 21212375 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive mobilization of shoulder region joints
Number of subjects: 98
Study 21212375 — intervention group
Group type: COMPARATOR
Intervention: Advice and exercises designed to restore neuromuscular control at the shoulder
Number of subjects: 98
Study 17884078 — intervention group
Group type: EXPERIMENTAL
Intervention: Effective applications of RF energy
Number of subjects: 95
Study 17884078 — intervention group
Group type: COMPARATOR
Intervention: Ineffective applications of RF energy
Number of subjects: 95
Study 17884078 — intervention group
Group type: EXPERIMENTAL
Intervention: Patterns of JR (sinus-junction-sinus, sinus-junction-junction, sinus-junction-block)
Number of subjects: 95
Study 16430795 — intervention group
Group type: EXPERIMENTAL
Intervention: CobraPLA (PLA)
Number of subjects: 90
Study 16430795 — intervention group
Group type: COMPARATOR
Intervention: Laryngeal Mask Airway (LMA)
Number of subjects: 90
Study 16430795 — intervention group
Group type: COMPARATOR
Intervention: Laryngeal Tube (LT)
Number of subjects: 90
Study 15035551 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg of terbutaline daily for 15 days starting on the day of oocyte retrieval (Group I)
Number of subjects: 225
Study 15035551 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg of ritodrine daily for 15 days (Group II)
Number of subjects: 225
Study 15035551 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Group III)
Number of subjects: 225
Study 10695846 — intervention group
Group type: EXPERIMENTAL
Intervention: Muncie method (home rehabilitation with modified VMO specific straight leg raise)
Number of subjects: 64
Study 10695846 — intervention group
Group type: COMPARATOR
Intervention: Traditional home rehabilitation
Number of subjects: 64
Study 10695846 — intervention group
Group type: COMPARATOR
Intervention: Physical therapy
Number of subjects: 64
Study 9177555 — intervention group
Group type: EXPERIMENTAL
Intervention: Target stimulus probability at 0.33
Number of subjects: 0
Study 9177555 — intervention group
Group type: EXPERIMENTAL
Intervention: Target stimulus probability at 0.67
Number of subjects: 0
Study 9177555 — intervention group
Group type: EXPERIMENTAL
Intervention: Interstimulus interval (ISI) of 2 s
Number of subjects: 0
Study 9177555 — intervention group
Group type: EXPERIMENTAL
Intervention: Interstimulus interval (ISI) of 6 s
Number of subjects: 0
Study 9177555 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulus sequence types (SS, TS, TT, ST)
Number of subjects: 0
Study 7697065 — intervention group
Group type: EXPERIMENTAL
Intervention: Arginine vasotocin (AVT)
Number of subjects: 33
Study 7697065 — intervention group
Group type: COMPARATOR
Intervention: Tricyclic antidepressants or cognitive-behavioral psychotherapy
Number of subjects: 33
Study 2869050 — intervention group
Group type: EXPERIMENTAL
Intervention: Methimazole (2 months before and 3 months after 131I therapy)
Number of subjects: 60
Study 2869050 — intervention group
Group type: COMPARATOR
Intervention: Betamethasone (3 weeks before and 4 weeks after 131I therapy)
Number of subjects: 60
Study 2869050 — intervention group
Group type: COMPARATOR
Intervention: 131I alone
Number of subjects: 60
Study 2869050 — intervention group
Group type: EXPERIMENTAL
Intervention: Betamethasone
Number of subjects: 60
Study 2869050 — intervention group
Group type: EXPERIMENTAL
Intervention: Methimazole and 131I
Number of subjects: 60
Study 30482676 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbal tea (Astragali Radix, Angelicae gigantis Radix, Zizyphi Fructus) consumed twice daily for 4 weeks
Number of subjects: 40
Study 30482676 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 40
Study 27106570 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-modeling brushing intervention delivered over the internet for 3 weeks
Number of subjects: 18
Study 27106570 — intervention group
Group type: COMPARATOR
Intervention: Control video condition
Number of subjects: 18
Study 24480774 — intervention group
Group type: EXPERIMENTAL
Intervention: DBM grafts placed between the proximal and distal segments
Number of subjects: 48
Study 24480774 — intervention group
Group type: COMPARATOR
Intervention: Control group (no grafts performed)
Number of subjects: 48
Study 23069726 — intervention group
Group type: EXPERIMENTAL
Intervention: Lubricant eye drops containing hydroxypropyl‐guar (HP‐guar) gelling agent (Systane Ultra)
Number of subjects: 30
Study 23069726 — intervention group
Group type: COMPARATOR
Intervention: Lubricant eye drops without gelling agent (Refresh Tears)
Number of subjects: 30
Study 23069726 — intervention group
Group type: EXPERIMENTAL
Intervention: HP‐guar group
Number of subjects: 30
Study 23069726 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study 20554640 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic exercise programme (3-6 weeks)
Number of subjects: 21
Study 20554640 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic exercise programme
Number of subjects: 21
Study 20554640 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 21
Study 18407418 — intervention group
Group type: EXPERIMENTAL
Intervention: Lyophilized bovine collagen (gelfix spray)
Number of subjects: 0
Study 18407418 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard dressing)
Number of subjects: 0
Study 15745938 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone replacement therapy
Number of subjects: 46
Study 15745938 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 12271411 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCTZ) 50 mg twice a day for 5 days
Number of subjects: 18
Study 12271411 — intervention group
Group type: COMPARATOR
Intervention: Control group (low-iodine diet only)
Number of subjects: 18
Study 12271411 — intervention group
Group type: COMPARATOR
Intervention: HCTZ group vs Control group
Number of subjects: 18
Study 10077366 — intervention group
Group type: EXPERIMENTAL
Intervention: Stapled closure with RLV 30 Ethicon 4.8 mm bronchial stapler
Number of subjects: 40
Study 10077366 — intervention group
Group type: COMPARATOR
Intervention: Hand sutured with 4 0 Prolene simple interrupted sutures
Number of subjects: 40
Study 7737863 — intervention group
Group type: EXPERIMENTAL
Intervention: Transnasal butorphanol
Number of subjects: 157
Study 7737863 — intervention group
Group type: COMPARATOR
Intervention: Transnasal placebo
Number of subjects: 157
Study 2248695 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium-rich diet (group A, 206 participants)
Number of subjects: 400
Study 2248695 — intervention group
Group type: COMPARATOR
Intervention: Usual diet (group B, 194 participants)
Number of subjects: 400
Study 6118171 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol 0.2 mg/kg
Number of subjects: 14
Study 6118171 — intervention group
Group type: EXPERIMENTAL
Intervention: Betaxolol 0.15 mg/kg
Number of subjects: 14
Study 6118171 — intervention group
Group type: EXPERIMENTAL
Intervention: Betaxolol 0.6 mg/kg
Number of subjects: 14
Study 6118171 — intervention group
Group type: EXPERIMENTAL
Intervention: Practolol 1 mg/kg
Number of subjects: 14
Study 6118171 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 0.2 mg/kg
Number of subjects: 14
Study 6118171 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 14
Study 31793882 — intervention group
Group type: EXPERIMENTAL
Intervention: PCI with everolimus‐eluting stents for trifurcation disease
Number of subjects: 605
Study 31793882 — intervention group
Group type: COMPARATOR
Intervention: PCI with everolimus‐eluting stents for bifurcation disease
Number of subjects: 605
Study 30165458 — intervention group
Group type: EXPERIMENTAL
Intervention: Total 3HC/Free COT during early pregnancy (12.5 weeks gestation)
Number of subjects: 47
Study 30165458 — intervention group
Group type: EXPERIMENTAL
Intervention: Total 3HC/Free COT during late pregnancy (28.9 weeks gestation)
Number of subjects: 47
Study 30165458 — intervention group
Group type: EXPERIMENTAL
Intervention: Total 3HC/Free COT postpartum (6 months after childbirth)
Number of subjects: 47
Study 30165458 — intervention group
Group type: EXPERIMENTAL
Intervention: Free 3HC/Free COT during early pregnancy (12.5 weeks gestation)
Number of subjects: 47
Study 30165458 — intervention group
Group type: EXPERIMENTAL
Intervention: Free 3HC/Free COT during late pregnancy (28.9 weeks gestation)
Number of subjects: 47
Study 30165458 — intervention group
Group type: EXPERIMENTAL
Intervention: Free 3HC/Free COT postpartum (6 months after childbirth)
Number of subjects: 47
Study 30165458 — intervention group
Group type: EXPERIMENTAL
Intervention: Total 3HC/Total COT over time
Number of subjects: 47
Study 30235767 — intervention group
Group type: EXPERIMENTAL
Intervention: Color Density Spectral Array (CDSA)
Number of subjects: 30
Study 30235767 — intervention group
Group type: EXPERIMENTAL
Intervention: Amplitude-Integrated Electroencephalography (aEEG)
Number of subjects: 30
Study 26710009 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone implants
Number of subjects: 50979
Study 26710009 — intervention group
Group type: COMPARATOR
Intervention: Saline implants
Number of subjects: 50979
Study 24168904 — intervention group
Group type: EXPERIMENTAL
Intervention: Dairy protein intake
Number of subjects: 0
Study 24168904 — intervention group
Group type: EXPERIMENTAL
Intervention: Total protein intake
Number of subjects: 0
Study 23231757 — intervention group
Group type: EXPERIMENTAL
Intervention: EAAMR (Essential Amino Acids Meal Replacement)
Number of subjects: 12
Study 23231757 — intervention group
Group type: COMPARATOR
Intervention: CMR (Competitive Meal Replacement)
Number of subjects: 12
Study 23231757 — intervention group
Group type: EXPERIMENTAL
Intervention: EAAMR
Number of subjects: 12
Study 23231757 — intervention group
Group type: COMPARATOR
Intervention: CMR
Number of subjects: 12
Study 19863513 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% aminolaevulinic acid (ALA)-PDT
Number of subjects: 45
Study 19863513 — intervention group
Group type: COMPARATOR
Intervention: Placebo-PDT
Number of subjects: 45
Study 17344325 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose atorvastatin (80 mg daily)
Number of subjects: 112
Study 17344325 — intervention group
Group type: COMPARATOR
Intervention: Low-dose atorvastatin (10 mg daily)
Number of subjects: 112
Study 15895534 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 11869201 — intervention group
Group type: EXPERIMENTAL
Intervention: Long pulse 532 nm potassium tritanyl phosphate (KTP) laser treatment for perialar vessels
Number of subjects: 39
Study 11869201 — intervention group
Group type: EXPERIMENTAL
Intervention: Long pulse 532 nm potassium tritanyl phosphate (KTP) laser treatment for spider naevi
Number of subjects: 39
Study 11869201 — intervention group
Group type: EXPERIMENTAL
Intervention: Long pulse 532 nm potassium tritanyl phosphate (KTP) laser treatment for both conditions
Number of subjects: 39
Study 9022602 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral estrone sulfate
Number of subjects: 18
Study 9022602 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal E2
Number of subjects: 18
Study 9022602 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 9022602 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen therapy in hypertensive women
Number of subjects: 18
Study 7835208 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with liver cirrhosis and diabetes mellitus (Group I)
Number of subjects: 34
Study 7835208 — intervention group
Group type: COMPARATOR
Intervention: Matched patients with only Type II DM (Group II)
Number of subjects: 34
Study 3277366 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin (titrated to a level of 1.54 to 2.56 nmol/liter)
Number of subjects: 20
Study 3277366 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 30321323 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed surgical exposure (n = 60)
Number of subjects: 119
Study 30321323 — intervention group
Group type: EXPERIMENTAL
Intervention: Open surgical exposure (n = 59)
Number of subjects: 119
Study 27383389 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based counselor guidance (choice group)
Number of subjects: 80
Study 27383389 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based counselor guidance (messages group)
Number of subjects: 80
Study 27383389 — intervention group
Group type: COMPARATOR
Intervention: Self-help program without guidance (control group)
Number of subjects: 80
Study 24659155 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week exercise training
Number of subjects: 96
Study 24659155 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week relaxation training
Number of subjects: 96
Study 24659155 — intervention group
Group type: COMPARATOR
Intervention: Wait list control group
Number of subjects: 96
Study 23367230 — intervention group
Group type: EXPERIMENTAL
Intervention: NMES therapy of quadriceps femoris and tibialis anterior muscles
Number of subjects: 10
Study 23367230 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy alone
Number of subjects: 10
Study 20367845 — intervention group
Group type: EXPERIMENTAL
Intervention: Multisystemic therapy
Number of subjects: 0
Study 17912003 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg oral mifepristone
Number of subjects: 180
Study 17912003 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study 16183952 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 5464
Study 16183952 — intervention group
Group type: COMPARATOR
Intervention: No adjuvant chemotherapy
Number of subjects: 5464
Study 15587176 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 1.875 mg x kg(‐1)
Number of subjects: 46
Study 15587176 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.9375 mg x kg(‐1)
Number of subjects: 46
Study 15587176 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.5625 mg x kg(‐1)
Number of subjects: 46
Study 15587176 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 46
Study 10689949 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone (maximum of 15 mg daily)
Number of subjects: 320
Study 9132132 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporal scleral incision made 2 mm posterior to the limbus
Number of subjects: 256
Study 9132132 — intervention group
Group type: COMPARATOR
Intervention: Incisions in the 12 o'clock position
Number of subjects: 256
Study 9132132 — intervention group
Group type: COMPARATOR
Intervention: Limbal incisions in the 12 o'clock position
Number of subjects: 256
Study 9132132 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporal limbal incision
Number of subjects: 256
Study 9132132 — intervention group
Group type: COMPARATOR
Intervention: Incision depth of 300 microns versus 500 microns
Number of subjects: 256
Study 9132132 — intervention group
Group type: COMPARATOR
Intervention: Age
Number of subjects: 256
Study 9132132 — intervention group
Group type: COMPARATOR
Intervention: Preoperative astigmatism
Number of subjects: 256
Study 8112904 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 99
Study 8112904 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study 8112904 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril in patients with heart failure
Number of subjects: 99
Study 8112904 — intervention group
Group type: COMPARATOR
Intervention: Placebo in patients with heart failure
Number of subjects: 99
Study 3533089 — intervention group
Group type: EXPERIMENTAL
Intervention: Bay m 1099 (50 mg)
Number of subjects: 12
Study 3533089 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 3276591 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadolol (40 to 120 mg per day)
Number of subjects: 79
Study 3276591 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo and ranitidine combined)
Number of subjects: 79
Study 3276591 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadolol
Number of subjects: 79
Study 3276591 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 79
Study 30374739 — intervention group
Group type: EXPERIMENTAL
Intervention: Nymphs kept at 400 ppm CO2 level and fed on plants grown at 700 ppm CO2 level
Number of subjects: 50
Study 30374739 — intervention group
Group type: EXPERIMENTAL
Intervention: Nymphs kept at 700 ppm CO2 level and fed on plants grown at 400 ppm CO2 level
Number of subjects: 50
Study 30374739 — intervention group
Group type: EXPERIMENTAL
Intervention: Nymphs and plants kept at 700 ppm CO2 level
Number of subjects: 50
Study 30374739 — intervention group
Group type: COMPARATOR
Intervention: Nymphs and plants kept at 400 ppm CO2 level
Number of subjects: 50
Study 30183818 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher starting point in face-to-face interviews
Number of subjects: 147
Study 30183818 — intervention group
Group type: COMPARATOR
Intervention: Lower starting point in face-to-face interviews
Number of subjects: 147
Study 26119285 — intervention group
Group type: EXPERIMENTAL
Intervention: Cream with aqueous extract from leaf of five-leaf serratula containing 2.51% of arbutin applied twice a day for 8 weeks
Number of subjects: 102
Study 23816030 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stents (EES)
Number of subjects: 1498
Study 23816030 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 1498
Study 21707560 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (150 μg) added to epidural low-concentration levobupivacaine (0.0625%) plus sufentanil (0.45 μg.ml(‐1))
Number of subjects: 115
Study 21707560 — intervention group
Group type: COMPARATOR
Intervention: Control group (no clonidine)
Number of subjects: 115
Study 21707560 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (150 μg) added to epidural solution
Number of subjects: 115
Study 19754965 — intervention group
Group type: EXPERIMENTAL
Intervention: CASCADE psycho-educational programme delivered in 4 group sessions over 4 months.
Number of subjects: 572
Study 19754965 — intervention group
Group type: COMPARATOR
Intervention: Standard care from clinical team (control group).
Number of subjects: 572
Study 19754965 — intervention group
Group type: EXPERIMENTAL
Intervention: CASCADE psycho-educational programme.
Number of subjects: 572